US SB366 | 2019-2020 | 116th Congress
Status
Spectrum: Partisan Bill (Democrat 7-0)
Status: Introduced on February 6 2019 - 25% progression, died in committee
Action: 2019-02-06 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S921-922)
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 6 2019 - 25% progression, died in committee
Action: 2019-02-06 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S921-922)
Pending: Senate Health, Education, Labor, And Pensions Committee
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to shorten monopoly periods for prescription drugs that are the subjects of sudden price hikes.
Title
FLAT Prices Act Forcing Limits on Abusive and Tumultuous Prices
Sponsors
Sen. Richard Durbin [D-IL] | Sen. Kamala Harris [D-CA] | Sen. Tina Smith [D-MN] | Sen. Amy Klobuchar [D-MN] |
Sen. Richard Blumenthal [D-CT] | Sen. Sherrod Brown [D-OH] | Sen. Gary Peters [D-MI] |
History
Date | Chamber | Action |
---|---|---|
2019-02-06 | Senate | Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S921-922) |
Same As/Similar To
HB1188 (Same As) 2019-02-14 - Referred to the Subcommittee on Health.
Subjects
Business records
Drug safety, medical device, and laboratory regulation
Government information and archives
Health
Health care costs and insurance
Inflation and prices
Licensing and registrations
Prescription drugs
Drug safety, medical device, and laboratory regulation
Government information and archives
Health
Health care costs and insurance
Inflation and prices
Licensing and registrations
Prescription drugs
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/senate-bill/366/all-info |
Text | https://www.congress.gov/116/bills/s366/BILLS-116s366is.pdf |